Philip Miller

Medicine & Life Sciences

1. African Americans 100%
2. Alzheimer Disease 95%
3. Duchenne Muscular Dystrophy 69%
4. Dementia 62%
5. Autosomal Dominant Polycystic Kidney 59%
6. Open Angle Glaucoma 53%
7. Ocular Hypertension 51%
8. Myocardial Infarction 46%
9. Polycystic Kidney Diseases 46%
10. Middle Aged 44%
11. Randomized Controlled Trials 41%
12. Mental Status and Dementia Tests 39%
13. Placebos 36%
14. Mortality 34%
15. Health 34%
16. Physical Functional Performance 33%
17. Accidental Falls 30%
18. Prednisone 28%
19. Narcotics 28%
20. Therapeutics 28%
21. Cognitive Dysfunction 26%
22. Infarction 26%
23. Clinical Trials 25%
24. Kidney 24%
25. Elderly 24%
26. Depression 24%
27. Muscle Strength 23%
28. Population 23%
29. Frailty 22%
30. Natural History 22%
31. Intraocular Pressure 22%
32. Confidence Intervals 22%
33. Stroke 21%
34. Cognition 19%
35. Cysts 19%
36. Nitrous Oxide 19%
37. Exercise 18%
38. Blood Pressure 18%
39. Psychometrics 17%
40. Health Care Outcome Assessment 17%
41. Interviews 17%
42. Veterans 17%
43. Prospective Studies 16%
44. Eye 16%
45. Amyloid Plaques 16%
46. Brain Mapping 16%
47. Education 16%
48. Venlafaxine Hydrochloride 15%
49. Child 15%
50. Contracture 15%